Sector portfolio · Growth fund · United States
Celgene's Biotech portfolio
Celgene has backed 17 Biotech startups in rounds we track, $3.2B between them, shown by the stage each has reached. The best-funded is Grail.
Funding by segment
- Series B$2.1B7
- Stage not reported$903M6
- Series C and later$205M4
Where they are based
- United States17$3.2B
United StatesFounded
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M4
- $50M to $250M10
- $250M to $1B2
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
13 of 17 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States17
Startups by country, 1 country in all.
Segment by segment
Series B
7 startups · $2.1B raised
- GGrailUnited States$1.6B
Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M- IIdeayaUnited States$94M
Evelo BiosciencesEvelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.United States$76M
Atara BiotherapeuticsAtara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.United States$69M- CBCleave BioscienceUnited States$37M
- FBFerroKin BiosciencesFerrokin Biosciences develops and markets medical devices such as Iron Chelator for the treatment of iron-overload in patients.United States$30M
Stage not reported
6 startups · $903M raised
EpizymeEpizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.United States$332M
CelularityCelularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.United States$270M- ABARMO BioSciencesARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.United States$117M
Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.United States$90M
Flexus BiosciencesFlexus Biosciences is a biotechnology company based in San Carlos, California, founded in 2013.United States$53M
SequentaSequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.United States$41M
Series C and later
4 startups · $205M raised
- GHGNS HealthcareUnited States$63M
CotaCOTA Healthcare is a healthcare technology company focused on oncology real-world data (RWD) and advanced analytics.United States$62M- FBFLX BioUnited States$60M
Presage BiosciencesPresage Biosciences develops a technology platform to improve the cancer drug development process.United States$20M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Celgene as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Celgene?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.